Committed to Making a Difference
Together, we're not just building homes, we're nurturing healthier, stronger communities.
We are proud to announce that 10% of our net commissions from real estate as a Limited Partner at Coyote Ventures will be dedicated to supporting women's health initiatives. This initiative reflects our steadfast commitment to empowering women and contributing to vital health causes.
“As a breast cancer survivor who is alive today because of early detection technology, the best way to express my gratitude is by becoming an investor in Coyote Ventures.”
-Melinda Moore, President, Moore Group
Coyote Ventures
Coyote Ventures is a venture capital fund that invests in early stage startups that are innovating women’s health and wellness. With 10 investments in our portfolio including Gabbi (risk assessment tool for breast cancer), Hera Biotech (world’s first non-surgical test capable of both staging and diagnosing endometriosis), Malama Health (a digital health platform to serve high risk pregnancies starting with gestational diabetes), and many more life changing companies.
Women’s health is a massively underserved market, valued at over a trillion dollars
Bank of America backed Coyote Ventures as the first institutional LP
Jessica Karr, the GP, is a former Impossible Foods Biochemist
Coyote Ventures Fund I LP wins US Emerging Manager Awards 2023
Best Performance, and top impact emerging fund manager by Impact Assets
Serena Ventures has invested alongside Coyote (WILE)